Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Hanne K. Høifødt"'
Autor:
Nils, Eide, Ragnar S, Faye, Hanne K, Høifødt, Berit, Sandstad, Geir, Qvale, Rowan, Faber, Peter, Jebsen, Gunnar, Kvalheim, Øystein, Fodstad
Publikováno v:
Acta Ophthalmologica. 93:59-66
Our objective was to study survival rates with the bone marrow (BM) results in a cohort of uveal melanoma patients with long follow-up.Mononuclear cell fractions isolated from BM were examined for tumour cells using our immunomagnetic separation (IMS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::064f79ca714f526ad4204bc69ea6a155
https://doi.org/10.1111/aos.12462
https://doi.org/10.1111/aos.12462
Autor:
Leiv Sandvik, Peter Jebsen, Nils Eide, Øystein Fodstad, Rowan Thomas Faber, Geir A. Qvale, Hanne K. Høifødt, Gunnar Kvalheim, Ragnar S. Faye
Publikováno v:
Pathology oncology research : POR. 25(1)
Approximately 50% of uveal melanoma patients develop metastases. We want to evaluate the effect of stricter criteria on our data from our previous study correlating survival and bone marrow (BM) micrometastasis results using our immunomagnetic separa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799beec1104ddba53037307fe25611d4
https://pubmed.ncbi.nlm.nih.gov/29098521
https://pubmed.ncbi.nlm.nih.gov/29098521
Autor:
Peter Jebsen, Rowan Thomas Faber, B. Sandstad, Nils Eide, Geir A. Qvale, Ragnar S. Faye, Gunnar Kvalheim, Hanne K. Høifødt, Øystein Fodstad
Publikováno v:
Acta Ophthalmologica. 87:830-836
Our objective was to introduce immunomagnetic separation (IMS) in ocular research by evaluating the possibility of detecting tumour cells in bone marrow (BM) and peripheral blood (PB) samples and validating the captured cells as melanocytic cells.Mon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2aae30ca767ef8333046e97ea86d2ea
https://doi.org/10.1111/j.1755-3768.2008.01378.x
https://doi.org/10.1111/j.1755-3768.2008.01378.x
Autor:
Øystein Fodstad, Wolfgang Lilleby, Piet J. Boender, Ase Bratland, Anne Hansen Ree, Mengyu Wang, Jens P. Berg, Hanne K. Høifødt, Rob Ruijtenbeek, Ingrid H.G. Østensen
Publikováno v:
Clinical & Experimental Metastasis. 26:485-496
Bone metastases in prostate cancer are predominantly osteoblastic. To study regulatory mechanisms underlying the establishment of prostate cancer within an osteoblastic microenvironment, human androgen-sensitive prostate carcinoma cells (LNCaP) were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f45ab7a02c308197f1a454e12844bcf2
https://doi.org/10.1007/s10585-009-9248-9
https://doi.org/10.1007/s10585-009-9248-9
Autor:
Ragnar S. Faye, Gunhild Mari Mælandsmo, Hanne K. Høifødt, Steinar Aamdal, Elisabeth Paus, Aasmund Berner, Øystein Fodstad
Publikováno v:
Melanoma Research. 18:134-140
The aim of this study was to evaluate S100B in bone marrow (BM) plasma from malignant melanoma patients. BM aspirates and peripheral blood (PB) plasma from 56 patients and BM aspirates from 29 healthy volunteers were collected. S100B was measured usi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05dc29913ce63f3a92ae48f3e32838e4
https://doi.org/10.1097/cmr.0b013e3282f623d9
https://doi.org/10.1097/cmr.0b013e3282f623d9
Publikováno v:
Clinical Cancer Research. 11:4666-4673
Bone marrow and peripheral blood samples from 60 patients with suspected bone sarcoma were examined for the presence and number of micrometastatic osteosarcoma cells by a sensitive immunomagnetic detection assay, using in parallel two osteosarcoma-as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b311d9dc1605dbeb76822debfc60b449
https://doi.org/10.1158/1078-0432.ccr-05-0165
https://doi.org/10.1158/1078-0432.ccr-05-0165
Autor:
Linn Holstad, Øystein Fodstad, Erling Jacobsen, Steinar Aamdal, Eva Skovlund, Ragnar S. Faye, Hanne K. Høifødt
Publikováno v:
Clinical Cancer Research. 10:4134-4139
Purpose: Positive associations between the presence of micrometastatic tumor cells and disease aggressiveness have been reported in several tumor types, but the clinical implications are still not established. We wanted to test a new, sensitive immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::090cb03e2f0e130e182540c4479784f3
https://doi.org/10.1158/1078-0432.ccr-03-0408
https://doi.org/10.1158/1078-0432.ccr-03-0408
Autor:
Olav Engebråten, Hanne K. Høifødt, Gunhild Mari Mælandsmo, Hans Petter Gullestad, Zhenhe Suo, Steinar Aamdal, Nirma Skrbo, Øystein Fodstad, Lina Prasmickaite
Publikováno v:
Pigment Cell & Melanoma Research. 23:449-451
Department of Tumour Biology, Oslo University Hospital Radiumhospital, Oslo, Norway Department of Pathology, Oslo University Hospital Radiumhospital, Oslo, Norway Faculty Division, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway Depar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e3c87c628728d9f636db359d135c09f
https://doi.org/10.1111/j.1755-148x.2010.00690.x
https://doi.org/10.1111/j.1755-148x.2010.00690.x
Publikováno v:
Molecular Pathology. 52:68-74
AIM: The presence of malignant cells in the blood and bone marrow of patients with cancer at the time of surgery may be indicative of early relapse. In addition to their numbers, the phenotypes of the micrometastatic cells might be essential in deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04deb4997cea52b1e60a99fb839182b6
https://doi.org/10.1136/mp.52.2.68
https://doi.org/10.1136/mp.52.2.68
Autor:
Anne Hansen Ree, Geir Olav Hjortland, Eivind Hovig, Klaus Beiske, Leonardo A. Meza-Zepeda, Sigbjørn Smeland, Øystein Fodstad, Per Johannes Bøhler, Knut Håkon Hole, Ola Myklebost, Siri Tveito, Hanne K. Høifødt
Publikováno v:
BMC Cancer, Vol 11, Iss 1, p 455 (2011)
BMC Cancer
BMC Cancer
Background Metastatic progression due to development or enrichment of therapy-resistant tumor cells is eventually lethal. Molecular characterization of such chemotherapy resistant tumor cell clones may identify markers responsible for malignant progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a9537fdbaccd5a8055814ff4bd26777
http://www.biomedcentral.com/1471-2407/11/455
http://www.biomedcentral.com/1471-2407/11/455